Africa's First Mpox Vaccines
This is a news story, published by Guardian, that relates primarily to WHO news.
News about vaccine development
For more vaccine development news, you can click here:
more vaccine development newsGuardian news
For more news from Guardian, you can click here:
more news from GuardianAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
Africa CDC. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest global health emergency news, global health emergencies news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
mpox vaccinesGuardian
•Africa to finally receive first batch of vaccines for deadly mpox virus
80% Informative
Mpox is a potentially deadly infection that causes flu-like symptoms and pus-filled lesions.
Vaccines have already been made available in more than 70 countries outside Africa .
Mpox was declared a global health emergency by the WHO on 14 August .
The Africa CDC has said that 10 m doses may be needed across the continent to cope with the outbreak.
VR Score
83
Informative language
82
Neutral language
48
Article tone
semi-formal
Language
English
Language complexity
67
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
2
Affiliate links
no affiliate links